This event will gather approximately 60 key representatives of our industry, including participants from the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products (URPL), the Supreme Bioethics Committee, and leaders from not-for-profit and industry associations, such as GCPpl, POLCRO, and Infarma. The meeting will be chaired by Dr. Ingrid Klingmann, a recognized European moderator for multi-stakeholder discussions and expert in clinical research methodology, regulatory affairs and ethics.
We will focus on jointly identifying actionable solutions for the Polish regulatory landscape by drawing on proven European and other countries’ national strategies to help accelerating the approval process. We aim at initiating a coordinated and impactful dialogue supported by data, legal insights, and economic analysis, leading to a joint position and recommendations paper.
Open dialogue and facilitate networking
Central presentation zone in a theatre-style setup
Cocktail tables for networking
Buffet with breakfast menu.
Medical doctor with 36+ years of experience in clinical development and general management across phases I–IV and multiple therapeutic areas. Worked with leading pharma (Abbott, Schering Plough), biotech (Amgen), and CROs (Kendle, INC). Holds an MD from Erasmus University, with clinical background in internal medicine and cardiology.
Legal expert with over 13 years of experience in clinical trials. She represented the Polish Ministry of Health in EU working groups on clinical trials (2012–2018) and co-authored the national Clinical Trials Act implementing the CTR. Currently, she provides legal and regulatory support at CRO Pure Clinical and serves as a legal advisor for Global Certification Body - an organization focused on quality and compliance across various industries. She is also a recognized GDPR expert.